Trials / Conditions / Hepatic Metastases

Hepatic Metastases

11 registered clinical trials studyying Hepatic Metastases.

Status	Trial	Sponsor	Phase
Completed	Targeted Delivery of Chemotherapy With Ultrasound and Microbublles NCT03458975	University Hospital, Tours	Phase 2
Unknown	the Efficacy and Safety of Sugammadex in Children 0-2 Years Old NCT03728543	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	Phase 2 / Phase 3
Withdrawn	Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma NCT03297463	Masonic Cancer Center, University of Minnesota	Phase 1 / Phase 2
Active Not Recruiting	Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Res NCT03364621	University Health Network, Toronto	—
Unknown	Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases NCT02913417	David Minor, MD	Phase 1 / Phase 2
Unknown	Study of the Practice of Debiri in France NCT03369041	Federation Francophone de Cancerologie Digestive	—
Completed	Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors NCT01678664	Federation Francophone de Cancerologie Digestive	Phase 2
Unknown	Resection of Colorectal Liver Metastases With or Without Routine Hilar Lymphadenectomy NCT01073358	Heidelberg University	N/A
Terminated	Evaluation of 2 Resection Strategies of Synchronous Colorectal Cancer Metastases NCT00264979	Rennes University Hospital	N/A
Completed	Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevaci NCT00200200	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases NCT00465023	Massachusetts General Hospital	N/A